Dextran 40 Glucose Injection
Function and Efficacy
This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.
Ingredients
This product is a sterile aqueous solution of dextran 40 and 5% glucose. Its average molecular weight is 40,000.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| DextranIngredients |
This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure; it can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis; it has an osmotic diuretic effect. More |
9004-54-0 | 16 | |
| GLUCOSEIngredients |
It acts as a solvent and energy supplement, and also assists dextran 40 in exerting its medicinal effects. More |
58367-01-4 | 15 |
Appearance
This product is a colorless, slightly viscous, clear liquid. Sometimes it has a slight opalescence and tastes sweet.
Indication
1. Shock, used for shock and toxic shock caused by various reasons such as blood loss, trauma, burns, etc. 2. Prevention of postoperative venous thrombosis, used for limb replantation and vascular surgery to prevent postoperative thrombosis. 3. Vascular embolic diseases, used for angina pectoris, cerebral thrombosis, cerebral blood supply insufficiency, thromboangiitis obliterans, etc. 4. During extracorporeal circulation, it replaces part of the blood and pre-fills the artificial heart-lung machine, which can save blood and improve circulation.
Usage and Dosage
Intravenous drip. The dosage depends on the condition. The common dosage for adults is 250-500 ml at a time. It should not exceed 1000 ml to 1500 ml within 24 hours. The dosage for infants is 5 ml/kg, and the dosage for children is 10 ml/kg. Shock cases: The dosage can be larger and the speed can be faster. The drip speed is 20-40 ml/min. The maximum dose on the first day can be up to 20 ml/kg. Dehydration must be corrected before use. Prevention of postoperative thrombosis: 500 ml is given during or after surgery, usually 500 ml/day on the first and second days after surgery. Intravenous drip at a speed of 2 to 4 hours. For high-risk patients, the course of treatment can be up to 10 days. Vascular embolic disease: It should be slowly dripped, generally 250 ml to 500 ml each time. Once a day or every other day. 7 to 10 times is a course of treatment.
Adverse Reactions
1. Allergic reaction. A small number of patients may experience allergic reaction, manifested as skin itching, urticaria, nausea, vomiting, and asthma. In severe cases, lips may become cyanotic and collapse. Blood pressure may drop sharply, bronchospasm may occur, and some patients may even experience anaphylactic shock and even death. The incidence of allergic reaction is about 0.03-4.7%. People with allergic constitution should undergo skin test before use. 2. Fever, chills, swollen lymph nodes, arthritis, etc. may occur occasionally. 3. Bleeding tendency, which may cause coagulation disorder and prolong bleeding time. This reaction is often related to the dose.
Precautions
1. Contraindicated for patients with congestive heart failure and other patients with excessive blood volume. 2. Contraindicated for patients with severe thrombocytopenia, coagulation disorders and other bleeding. 3. Use with caution in patients with poor heart, liver and kidney function; contraindicated for patients with oliguria or anuria. 4. Use with caution in patients with active pulmonary tuberculosis. 5. Use with caution in patients with a history of allergies. Contraindicated for patients with oliguria or anuria. [Use with caution in athletes].
Special Population Medication
Precautions for children: There is currently a lack of detailed research data. Precautions for pregnancy and lactation: Do not use it together with painkillers or epidural anesthesia during childbirth for prevention or treatment. If the mother is allergic to dextran or has an anaphylactic reaction, it may cause excessive uterine tension and fetal hypoxia. There is a risk of death or serious consequences to the infant's nervous system. Precautions for the elderly: There is currently a lack of detailed research data.
Drug Interactions
1. When used in combination with heparin, the possibility of bleeding increases due to synergistic effects. 2. When used in combination with chloramphenicol and paromomycin, nephrotoxicity may increase.
Storage
Store below 25°C.
Packaging Specification
500m: 30g dextran 40 and 25g glucose
Validity Period
24 months
Manufacturer
Luan Worldbest Pharmaceuticals Co., Ltd.
-
Founded in:
1998-06-01 -
Address:
The intersection of Gaocheng East Road and Jingliu Road, Economic and Technological Development Zone, Lu'an City, Anhui Province -
Tax NO.:
91340000152947607T -
Registered Funds:
200 million yuan -
Email: